District Court: Incorporation by Reference for Purposes of Anticipation Requires More than a Parenthetical

March 13, 2025

Reading Time : 2 min

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

This patent infringement case involved patents directed to methods for detecting nucleic acids. Defendant advanced two anticipation defenses, both of which were premised on the incorporation of material from one reference into another. Specifically, defendant contended that the asserted patents were anticipated by either (i) the Larsson Dissertation incorporating by reference the Göransson article, or (ii) the Gunderson article incorporating by reference the Levsky article.

Plaintiffs moved in limine under FRE 402 and 403 to preclude defendant from these arguments, contending both anticipation defenses relied on material that was not adequately incorporated by reference. In their motion, plaintiffs noted that the Larsson Dissertation included citations to 131 different publications in its text, but only cited to Göransson three times. Similarly, the text of Gunderson referenced Levsky only once in a parenthetical. Plaintiffs contended that these were “routine academic citations” that failed to make clear what material was being incorporation into the primary reference. 

The court agreed with plaintiffs regarding Gunderson, and held that the lone textual citation to Levsky did not identify any specific material from Levsky that was being incorporated into Gunderson. Although Gunderson described the contents of Levsky in a parenthetical, this was, in the court’s view, the equivalent of a “bare footnote” that fell short of the detailed particularity required for incorporation. The court therefore precluded defendant from presenting any testimony or arguments regarding the Gunderson/Levsky defense.

The court reached the opposite conclusion regarding the Larsson Dissertation and its incorporation of Göransson. In so doing, the court pointed out that the Larsson Dissertation substantively discusses Göransson in three passages, including specific teachings about its strategies and methods for detecting nucleic acids. The court also credited the unrebutted testimony by defendant’s expert discussing each of those instances and explaining that one skilled in the art would have understood the Larsson Dissertation to incorporate specific teachings from Göransson. 

 Practice Tip: When considering an anticipation theory premised on incorporation by reference, a defendant should carefully evaluate whether the primary reference includes specific discussion of the secondary reference and clearly identifies where that subject matter is found. A defendant advancing such a theory should also consider having an expert describe each instance where the secondary reference is mentioned and provide an opinion as to whether a person of ordinary skill in the art would have understood the primary reference to have incorporated the specific teachings from the secondary reference.

Case: 10X Genomics, Inc. et al. v. Vizgen Inc., 1:22-cv-00595 (DDE Jan. 30, 2025) (Kennelly)

 

Share This Insight

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.